BIOS - BioScrip, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

BioScrip, Inc.

1600 Broadway
Suite 700
Denver, CO 80202
United States

IndustryMedical Care
Full Time Employees1,657

Key Executives

NameTitlePayExercisedYear Born
Mr. Daniel E. GreenleafCEO, Pres & Director749.52kN/A1965
Mr. Stephen M. DeitschSr. VP, CFO & Treasurer375kN/A1973
Ms. Harriet BookerSr. VP & COO415kN/A1966
Ms. Kathryn M. StalmackSr. VP, Gen. Counsel & Sec.338kN/AN/A
Mr. John McMahonVP, Controller & Chief Accounting OfficerN/AN/A1965
Amounts are as of December 31, 2018 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


BioScrip, Inc. provides infusion and home care management solutions in the United States. It engages in the preparation, delivery, administration, and clinical monitoring of pharmaceutical treatments that are administered to a patient through intravenous, subcutaneous, intramuscular, intra-spinal, and enteral methods. The company is primarily involved in the intravenous administration of medications to treat a range of acute and chronic conditions, such as infections, nutritional deficiencies, immunologic and neurologic disorders, cancer, pain, and palliative care. It also offers home nursing products and services to patients suffering from chronic and acute medical conditions. The company provides its services at patient's home, outpatient clinics, nursing facilities, physician's offices, and ambulatory infusion centers. BioScrip, Inc. offers its solutions through sales and marketing representatives, and payor relationships. The company was incorporated in 1996 and is based in Denver, Colorado.

Corporate Governance

BioScrip, Inc.’s ISS Governance QualityScore as of April 1, 2019 is 6. The pillar scores are Audit: 10; Board: 2; Shareholder Rights: 7; Compensation: 6.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.